Jan. 29, 2020

LEO Science & Tech Hub Forges Life Sciences Collaborations with Venture Café Tokyo

In a new partnership, the LEO Science & Tech Hub and Venture Café Tokyo share a core aim – to bolster a flourishing life sciences ecosystem in Japan.

In a new partnership, the LEO Science & Tech Hub and Venture Café Tokyo share a core aim – to bolster a flourishing life sciences ecosystem in Japan.

With its mission of “connecting innovators to make things happen,” Venture Café Tokyo works to connect innovators through attractive spaces, programs and stories. Venture Café Tokyo reaches an ecosystem that spans entrepreneurs, new business development, investors, educators and policymakers. It is an open community.

The cluster program will regularly invite innovators at the forefront of selected science and healthcare areas during Thursday discussion sessions, open to the community and looking to the future. These sessions will feature experts and thought-leaders seeking possible ways to overcome barriers to innovation and drive greater opportunity within Japanese life sciences.

LEO Science & Tech Hub Forges Life Sciences Collaborations with Venture Café Tokyo

“We are truly excited to sponsor and partner with Venture Café Tokyo on this cluster program, which we hope will grow and expand,” says Tord Labuda, Ph.D. Vice President, Research and Development, Asia-Pacific Hub, LEO Pharma. “I am really impressed with how they are driving innovation by creating a positive, collaborative atmosphere thriving with opportunities.”

“It is clear that Japan has high standards for science and technology, however we need greater translation of basic research into real-world solutions – a need where start-ups may be able to play a significant role,” says Taruho Kuroda, Director, LEO Science & Tech Hub, Japan, who is helping coordinate the partnership. “In recent years, the life sciences start-up scene in Japan has become more and more active and seen as an attractive market for venture investment.”

By activating the Japanese life sciences scene, more innovations have the potential to be translated into medical solutions helping patients, Taruho adds.

The LEO Science & Tech Hub sees its role as a catalyst connecting dots as well as this being a way to raise visibility of the company and its innovation ecosystem within Japan. The partnership also introduces the company to active innovators in Tokyo, Japan and beyond.

“We are so excited to partner with LEO Science & Tech Hub to launch our life science cluster program at Venture Café Tokyo,” says Yasuhiro Yamakawa, Ph.D. Executive Director, Venture Café Tokyo, and Associate Professor of Entrepreneurship, Babson College. “Combining LEO Pharma’s strong leadership in the field of dermatology and our expanding global network, currently in 11 cities across 6 countries, we hope to innovate together to better the world. By connecting innovators to make things happen, we will.”

MAT-31450. January 2020.

News from the hub

Aug. 2020 18 Journal of Investigative Dermatology Highlights Data from LEO Science & Tech Hub Partnership with Epicore Biosystems, Inc.

The Journal of Investigative Dermatology (JID) recently published “Rapid Capture and Extraction of Sweat for Regional Rate and Cytokine Composition Analysis Using a Wearable Soft Microfluidic System” in its Letters to the Editor. The article highlights a study involving Epicore Biosystems, Inc.’s soft, skin-interfaced microfluidic patch in development to enable rapid capture and extraction of sweat volumes for the analysis of cytokines.

Read more
Jun. 2020 23 Partners of the LEO Science & Tech Hub Independently Explore Potential Technology in COVID-19 Response

Two LEO Science & Tech Hub partners – outside of their partnerships with the Hub – are looking at how different technologies in development could possibly help patients and healthcare providers affected by the COVID-19 pandemic.

Read more